Last Close
Apr 02  •  04:00PM ET
17.24
Dollar change
-0.01
Percentage change
-0.06
%
IndexRUT P/E- EPS (ttm)-4.35 Insider Own65.37% Shs Outstand8.95M Perf Week-4.28%
Market Cap158.04M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.17M Perf Month-14.19%
Enterprise Value189.64M PEG- EPS next Q-0.04 Inst Own21.17% Short Float6.84% Perf Quarter-26.17%
Income-37.56M P/S1.53 EPS this Y420.00% Inst Trans23.07% Short Ratio3.24 Perf Half Y-44.03%
Sales103.14M P/B25.97 EPS next Y- ROA-7.22% Short Interest0.22M Perf YTD-26.17%
Book/sh0.66 P/C9.53 EPS next 5Y- ROE-25.64% 52W High35.95 -52.04% Perf Year-42.67%
Cash/sh1.81 P/FCF73.17 EPS past 3/5Y-63.11% -41.80% ROIC-69.85% 52W Low16.05 7.44% Perf 3Y-58.21%
Dividend Est.- EV/EBITDA25.02 Sales past 3/5Y31.03% 45.92% Gross Margin89.30% Volatility6.20% 6.39% Perf 5Y-48.04%
Dividend TTM- EV/Sales1.84 EPS Y/Y TTM-282.10% Oper. Margin3.94% ATR (14)1.19 Perf 10Y129.87%
Dividend Ex-Date- Quick Ratio1.59 Sales Y/Y TTM19.01% Profit Margin-36.42% RSI (14)39.59 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.80 EPS Q/Q-5.38% SMA20-6.60% Beta1.16 Target Price36.00
Payout- Debt/Eq8.11 Sales Q/Q4.72% SMA50-12.25% Rel Volume0.19 Prev Close17.25
Employees108 LT Debt/Eq8.05 EarningsMar 24 BMO SMA200-32.74% Avg Volume66.98K Price17.24
IPOApr 07, 1994 Option/ShortNo / Yes EPS/Sales Surpr.-218.18% 0.53% Trades Volume12,953 Change-0.06%
Date Action Analyst Rating Change Price Target Change
Mar-26-25Reiterated H.C. Wainwright Buy $50 → $51
Dec-23-24Initiated H.C. Wainwright Buy $50
May-20-22Resumed Cantor Fitzgerald Overweight $45 → $40
Jun-30-21Initiated Cantor Fitzgerald Overweight $45
Mar-25-26 08:30AM
Mar-24-26 03:01PM
07:00AM
Mar-23-26 09:20AM
Mar-11-26 07:30AM
06:05PM Loading…
Mar-03-26 06:05PM
07:30AM
Feb-17-26 07:30AM
Jan-23-26 07:30AM
Jan-07-26 04:05PM
Jan-06-26 12:00PM
11:39AM
Dec-10-25 08:37AM
Nov-19-25 07:30AM
Nov-12-25 02:02PM
09:35AM Loading…
09:35AM
07:00AM
Nov-11-25 04:05PM
07:30AM
Nov-05-25 09:25AM
Oct-29-25 05:55PM
Oct-01-25 07:30AM
Sep-02-25 04:30PM
Aug-27-25 04:05PM
Aug-13-25 08:25AM
07:00AM
Aug-12-25 09:33AM
Aug-07-25 10:05AM
Jul-15-25 04:05PM
Jul-14-25 04:05PM
03:06AM Loading…
May-15-25 03:06AM
May-14-25 08:50AM
07:00AM
May-13-25 09:39AM
May-08-25 05:15PM
Apr-23-25 08:00AM
Apr-10-25 04:00PM
11:36AM
Mar-26-25 03:01AM
Mar-25-25 09:15AM
07:00AM
Mar-24-25 09:04AM
Mar-11-25 04:05PM
Jan-24-25 07:00AM
Jan-21-25 04:10PM
04:08PM
04:05PM
Nov-25-24 04:05PM
Nov-14-24 02:10AM
Nov-12-24 04:15PM
Nov-11-24 07:17AM
Oct-31-24 09:15AM
Oct-07-24 09:15AM
Sep-11-24 06:30AM
Aug-12-24 04:15PM
Jul-30-24 09:15AM
May-15-24 03:05AM
May-13-24 10:54PM
10:52AM
09:15AM
Apr-29-24 09:15AM
Apr-18-24 09:15AM
Apr-05-24 09:00AM
Mar-29-24 09:41AM
Mar-25-24 08:53PM
05:52PM
04:05PM
Mar-13-24 09:15AM
Feb-22-24 09:15AM
Jan-03-24 09:15AM
Nov-30-23 09:15AM
Nov-15-23 01:44PM
Nov-13-23 05:29PM
04:05PM
Oct-30-23 09:15AM
Oct-10-23 09:15AM
Sep-12-23 09:15AM
Aug-14-23 04:05PM
Aug-02-23 09:15AM
Aug-01-23 04:05PM
May-15-23 04:15PM
May-03-23 09:15AM
Apr-04-23 09:15AM
Mar-20-23 04:15PM
Mar-06-23 09:15AM
Feb-22-23 09:15AM
Nov-21-22 09:15AM
Nov-14-22 04:15PM
Nov-03-22 09:15AM
06:30AM
Nov-01-22 09:15AM
Sep-06-22 09:15AM
Aug-17-22 08:44AM
Aug-15-22 04:15PM
Aug-11-22 06:29AM
Aug-03-22 09:15AM
Jul-05-22 09:15AM
Jun-12-22 10:12AM
May-16-22 04:30PM
May-11-22 07:42AM
Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.